GNLX
Genelux Corporation
There isn't enough reported data to score GNLX yet.
GNLX Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Unavailable | |
| Unavailable |
GNLX's revenue and profitability are currently under pressure. There isn't enough data to rate its cash flow and balance sheet.
GNLX PE Valuation
GNLX has no meaningful PE right now: it lost money over the past year.
GNLX Forward outlook
There aren't enough analyst estimates for GNLX to show an outlook.
GNLX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.86 | -$0.01 |
| Q1 2026 | -$0.85 | +$0.02 |
| Q4 2025 | -$0.86 | +$0.09 |
| Q3 2025 | -$0.87 | +$0.03 |
| Q2 2025 | -$0.85 | +$0.06 |
| Q1 2025 | -$0.87 | +$0.05 |
| Q4 2024 | -$0.95 | +$0.21 |
| Q3 2024 | -$0.90 | +$0.19 |
GNLX is still losing money, but less than at its worst: $0.86 per share over the past year, against $1.16 at its worst in late 2023.
GNLX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2024 | $8K | -95% |
GNLX's revenue has slid since its 2022 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2024 | -101438% | -97636 points |
| Q1 2023 | -3801% | N/A |
| Q4 2022 | -4550% | N/A |
| Q3 2022 | 58% | N/A |
GNLX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$8M | -$802K |
| Q1 2026 | -$7M | -$1.5M |
| Q4 2025 | -$6.6M | -$2.2M |
| Q3 2025 | -$7.1M | -$1.3M |
| Q2 2025 | -$7.2M | -$122K |
| Q1 2025 | -$5.5M | -$1.1M |
| Q4 2024 | -$4.4M | +$2.8M |
| Q3 2024 | -$5.8M | -$2.1M |
GNLX has burned cash in almost every quarter: −$29M over the past year, against −$23M the year before.
GNLX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.8% | +808K shares |
| 1 year | +18% | +7M shares |
| 3 years | +79% | +19.9M shares |
| 5 years | +111% | +23.7M shares |
| Available history | +90% | +21.3M shares |
GNLX has 45M diluted shares, up 18% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
GNLX Net Leverage
GNLX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GNLX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.8 | Neutral |
| Stochastic | 14.5 | Oversold |
GNLX's weekly RSI is 31 (neutral) and its Stochastic is 15 (oversold).
GNLX PE vs Healthcare Sector
GNLX has no meaningful PE right now: it lost money over the past year.
GNLX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.25 | 16% below |
| 20 week MA | $2.55 | 25% below |
| 50 week MA | $2.84 | 33% below |
| 100 week MA | $3.29 | 42% below |
GNLX is in a downtrend: it's below all four of its weekly moving averages, and 42% below its 100-week average.
GNLX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $6.01 | $14.0 | +133% |
| 2024 | $14.0 | $2.48 | -82% |
| 2025 | $2.48 | $4.37 | +76% |
| 2026 YTD | $4.37 | $1.90 | -57% |
GNLX's yearly returns have swung widely, from +133% in 2023 to −82% in 2024. It's down 57% so far in 2026.